Avantor (AVTR) Cash from Investing Activities (2018 - 2025)
Avantor's (AVTR) quarterly Cash from Investing Activities came in at -$28.9 million in Q1 2025, up 15.5% year-on-year from -$25.0 million in Q1 2024, and up 35.63% quarter-over-quarter from -$44.9 million in Q2 2024.
Avantor (AVTR) Cash from Investing Activities (2018 - 2025) Analysis & Trends
Avantor's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$28.9 million for Q1 2025.
- On a quarterly basis, Cash from Investing Activities rose 15.5% year-over-year to -$28.9 million in Q1 2025; TTM through Mar 2025 was -$158.0 million, a 4.91% decrease from a year earlier, with the FY2025 full-year figure at -$130.5 million, down 129.73% from the prior year.
- Cash from Investing Activities climbed to -$28.9 million in Q1 2025 per AVTR's latest filing, from -$44.9 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$14.6 million in Q1 2021 and bottomed at -$2.9 billion in Q4 2021.
- The 4-year median for Cash from Investing Activities is -$34.3 million (2021), against an average of -$397.6 million.
- Across the five-year window, Cash from Investing Activities sank 15237.77% in 2021 and grew 15.5% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$2.9 billion in 2021, then jumped by 98.27% to -$50.0 million in 2023, then gained by 10.2% to -$44.9 million in 2024, then jumped by 35.63% to -$28.9 million in 2025.
- Per Business Quant, the three latest AVTR Cash from Investing Activities figures stand at -$28.9 million (Q1 2025), -$44.9 million (Q2 2024), and -$34.2 million (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Avantor | 8.00 Bn | 7.72 Bn | 500.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -28.90 Mn |
| Mar 31, 2025 | -28.90 Mn |
| Jun 30, 2024 | -44.90 Mn |
| Jun 30, 2024 | -44.90 Mn |
| Mar 31, 2024 | -34.20 Mn |
| Mar 31, 2024 | -34.20 Mn |
| Dec 31, 2023 | -50.00 Mn |
| Dec 31, 2023 | -50.00 Mn |
| Sep 30, 2023 | -37.00 Mn |
| Sep 30, 2023 | -37.00 Mn |
| Jun 30, 2023 | -29.40 Mn |
| Jun 30, 2023 | -29.40 Mn |
| Mar 31, 2023 | -27.30 Mn |
| Mar 31, 2023 | -27.30 Mn |
| Dec 31, 2021 | -2.88 Bn |
| Dec 31, 2021 | -2.88 Bn |
| Sep 30, 2021 | -34.30 Mn |
| Sep 30, 2021 | -34.30 Mn |
| Jun 30, 2021 | -1.19 Bn |
| Jun 30, 2021 | -1.19 Bn |